Latest news

  • Sugar ‘by-product’ link to womb, pregnancy health uncovered

    A woman’s pre-pregnancy diet could have a greater impact on fertility and pregnancy than previously thought, according to new research by Hudson Institute of Medical Research scientists. The study found that certain proteins, which become ‘toxic’ after exposure to sugar, trigger inflammation in the womb in infertile women with obesity. This may reduce the likelihood…  Read more

  • Hope for ovarian cancer treatments

    Precision medicine is providing new hope for patients with ovarian cancer, the most common cause of death from gynaecological cancers. Only 3 out of every 10 women diagnosed with advanced stage ovarian cancer will survive after five years. These statistics haven’t improved in 30 years, but precision medicine approaches are opening up new possibilities. While…  Read more

  • Boys, girls and intersex conditions

    Hudson Institute researchers are closer to understanding the fundamental processes that make embryos develop as male, helping the 1 in 5000 babies that are born intersex. Scientists had already established that the protein, SOX9, is a crucial regulator of male sex development, directing the testes to form within a developing embryo; yet how SOX9 did…  Read more

  • Fighting a deadly pandemic

    Why do seasonal strains of influenza make many people sick yet cause relatively few deaths, while 40 per cent of people affected by strains of avian influenza, or ‘bird flu’, succumb to their infection? A discovery by Associate Professor Ashley Mansell could form a strategy to protect the world’s population from a potential global outbreak…  Read more

  • New genetic explanation for intersex provides hope

    A study led by Professor Vincent Harley and Dr Daniel Bird examining the genetic causes of intersex, where a person is born with characteristics that are not clearly male or female, has been selected in ‘The Best of 2017′ Endocrine Society journals list. About 1 in 5000 babies are born with disorders of sex development…  Read more

  • Length does matter – looking at micro-RNAs to predict cancer and disease

    A world-first study has shown ‘length does matter’ when using small molecules called microRNAs as potential biomarkers to detect and predict cancer and inflammatory diseases. The study, published in the journal RNA, was led by Dr Michael Gantier and PhD student Ms Charlotte Nejad at Hudson Institute, together with collaborators from Monash University, Royal College…  Read more

  • Hudson Institute student a FameLab semi-finalist

    PhD student, Aidan Kashyap has been selected as a FameLab semi-finalist for his research that is offering hope for babies who struggle to breathe at birth due to underdeveloped lungs. Aidan will compete against 11 other STEM early career researchers in the FameLab Victorian semi-finals at the Melbourne Museum on Wednesday (28 March). FameLab, presented…  Read more

  • Hudson Institute enters into research alliance with Invion Limited

    Hudson Institute has entered into a Research and Development Alliance Agreement with Invion Limited to advance Invion’s cancer treatment technology, Photosoft. The collaboration will initially focus on the treatment of ovarian cancer, with a view to expanding research and development projects into other forms of cancer. Hudson Institute will provide the research facilities and expertise…  Read more

  • Dr Sue Fowler Scholarship in Ovarian Cancer awarded to Mrs Nazanin Karimnia

    The inaugural Dr Sue Fowler Scholarship in Ovarian Cancer has been awarded to PhD student, Mrs Nazanin Karimnia to support her research into new ovarian cancer therapies. The scholarship was established in honour of the late Dr Sue Fowler, to support a Hudson Institute PhD student undertaking research into ovarian cancer. There is an urgent…  Read more

  • High-dose steroids don’t prevent asthma flare-ups

    High doses of glucocorticoids are not effective in preventing life-threatening asthma flare-ups, according to a landmark study published in The New England Journal of Medicine (NEJM). Glucocorticoids are anti-inflammatory medications used in many everyday prescription asthma puffers, such as turbuhalers or accuhalers. Hudson Institute research group head, Professor Phil Bardin was invited by the NEJM…  Read more